369 related articles for article (PubMed ID: 27917698)
1. Tetramethylpyrazine Protects Against Glucocorticoid-Induced Apoptosis by Promoting Autophagy in Mesenchymal Stem Cells and Improves Bone Mass in Glucocorticoid-Induced Osteoporosis Rats.
Wang L; Zhang HY; Gao B; Shi J; Huang Q; Han YH; Hu YQ; Lu WG; Zhao ZJ; Liu BH; Jie Q; Yang L; Luo ZJ
Stem Cells Dev; 2017 Mar; 26(6):419-430. PubMed ID: 27917698
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoids induce autophagy in rat bone marrow mesenchymal stem cells.
Wang L; Fan J; Lin YS; Guo YS; Gao B; Shi QY; Wei BY; Chen L; Yang L; Liu J; Luo ZJ
Mol Med Rep; 2015 Apr; 11(4):2711-6. PubMed ID: 25515523
[TBL] [Abstract][Full Text] [Related]
3. Tetramethylpyrazine Protects Bone Marrow-Derived Mesenchymal Stem Cells against Hydrogen Peroxide-Induced Apoptosis through PI3K/Akt and ERK1/2 Pathways.
Fang Y; Chu L; Li L; Wang J; Yang Y; Gu J; Zhang J
Biol Pharm Bull; 2017 Dec; 40(12):2146-2152. PubMed ID: 28978811
[TBL] [Abstract][Full Text] [Related]
4. Cladrin alleviates dexamethasone-induced apoptosis of osteoblasts and promotes bone formation through autophagy induction via AMPK/mTOR signaling.
Rai R; Singh KB; Khanka S; Maurya R; Singh D
Free Radic Biol Med; 2022 Sep; 190():339-350. PubMed ID: 35998794
[TBL] [Abstract][Full Text] [Related]
5. Anti‑osteoporotic effects of tetramethylpyrazine via promoting osteogenic differentiation and inhibiting osteoclast formation.
Wang L; Lu WG; Shi J; Zhang HY; Xu XL; Gao B; Huang Q; Li XJ; Hu YQ; Jie Q; Luo ZJ; Yang L
Mol Med Rep; 2017 Dec; 16(6):8307-8314. PubMed ID: 28983593
[TBL] [Abstract][Full Text] [Related]
6. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N
Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508
[TBL] [Abstract][Full Text] [Related]
7. Autophagy as a target for glucocorticoid-induced osteoporosis therapy.
Shen G; Ren H; Shang Q; Qiu T; Yu X; Zhang Z; Huang J; Zhao W; Zhang Y; Liang D; Jiang X
Cell Mol Life Sci; 2018 Aug; 75(15):2683-2693. PubMed ID: 29427075
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid-induced autophagy and apoptosis in bone.
Wang T; Liu X; He C
Apoptosis; 2020 Apr; 25(3-4):157-168. PubMed ID: 32157482
[TBL] [Abstract][Full Text] [Related]
9. Autophagy regulates the apoptosis of bone marrow-derived mesenchymal stem cells under hypoxic condition via AMP-activated protein kinase/mammalian target of rapamycin pathway.
Zhang Z; Yang M; Wang Y; Wang L; Jin Z; Ding L; Zhang L; Zhang L; Jiang W; Gao G; Yang J; Lu B; Cao F; Hu T
Cell Biol Int; 2016 Jun; 40(6):671-85. PubMed ID: 27005844
[TBL] [Abstract][Full Text] [Related]
10. Preconditioning of bone marrow-derived mesenchymal stromal cells by tetramethylpyrazine enhances cell migration and improves functional recovery after focal cerebral ischemia in rats.
Li L; Chu L; Fang Y; Yang Y; Qu T; Zhang J; Yin Y; Gu J
Stem Cell Res Ther; 2017 May; 8(1):112. PubMed ID: 28499457
[TBL] [Abstract][Full Text] [Related]
11. Pinocembrin alleviates glucocorticoid-induced apoptosis by activating autophagy via suppressing the PI3K/Akt/mTOR pathway in osteocytes.
Wang XY; Gong LJ; Huang JM; Jiang C; Yan ZQ
Eur J Pharmacol; 2020 Aug; 880():173212. PubMed ID: 32470335
[TBL] [Abstract][Full Text] [Related]
12. Galangin mitigates glucocorticoid-induced osteoporosis by activating autophagy of BMSCs via triggering the PKA/CREB signaling pathway.
Zeng C; Wang S; Gu H; Chen F; Wang Z; Li J; Xie Z; Feng P; Shen H; Wu Y
Acta Biochim Biophys Sin (Shanghai); 2023 Jun; 55(8):1275-1287. PubMed ID: 37365870
[TBL] [Abstract][Full Text] [Related]
13. Zuo-Gui-Wan Aqueous Extract Ameliorates Glucocorticoid-Induced Spinal Osteoporosis of Rats by Regulating let-7f and Autophagy.
Shen G; Shang Q; Zhang Z; Zhao W; Chen H; Mijiti I; Chen G; Yu X; Yu F; Zhang P; He J; Zhang X; Tang J; Cui J; Liang D; Zeng L; Ren H; Jiang X
Front Endocrinol (Lausanne); 2022; 13():878963. PubMed ID: 35592785
[TBL] [Abstract][Full Text] [Related]
14. Macrophage migration inhibitory factor induces autophagy to resist hypoxia/serum deprivation-induced apoptosis via the AMP-activated protein kinase/mammalian target of rapamycin signaling pathway.
Xia W; Hou M
Mol Med Rep; 2016 Mar; 13(3):2619-26. PubMed ID: 26847932
[TBL] [Abstract][Full Text] [Related]
15. Gastrodin protects MC3T3-E1 osteoblasts from dexamethasone-induced cellular dysfunction and promotes bone formation via induction of the NRF2 signaling pathway.
Liu S; Fang T; Yang L; Chen Z; Mu S; Fu Q
Int J Mol Med; 2018 Apr; 41(4):2059-2069. PubMed ID: 29393365
[TBL] [Abstract][Full Text] [Related]
16. Strontium gluconate potently promotes osteoblast development and restores bone formation in glucocorticoid-induced osteoporosis rats.
Dai L; Chen X; Xiong Y; Chen J; Li J; Li D; Zhou G; Zou Y; Liu T
Biochem Biophys Res Commun; 2021 May; 554():33-40. PubMed ID: 33774277
[TBL] [Abstract][Full Text] [Related]
17. Autophagy protects bone marrow mesenchymal stem cells from palmitate‑induced apoptosis through the ROS‑JNK/p38 MAPK signaling pathways.
Liu Y; Wang N; Zhang S; Liang Q
Mol Med Rep; 2018 Aug; 18(2):1485-1494. PubMed ID: 29901107
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic Mesenchymal Stem Cell Therapy Promotes Osteoblastogenesis and Prevents Glucocorticoid-Induced Osteoporosis.
Sui B; Hu C; Zhang X; Zhao P; He T; Zhou C; Qiu X; Chen N; Zhao X; Jin Y
Stem Cells Transl Med; 2016 Sep; 5(9):1238-46. PubMed ID: 27365487
[TBL] [Abstract][Full Text] [Related]
19. Hesperetin alleviated glucocorticoid-induced inhibition of osteogenic differentiation of BMSCs through regulating the ERK signaling pathway.
Liu L; Zheng J; Yang Y; Ni L; Chen H; Yu D
Med Mol Morphol; 2021 Mar; 54(1):1-7. PubMed ID: 32253606
[TBL] [Abstract][Full Text] [Related]
20. Silencing miR-106b accelerates osteogenesis of mesenchymal stem cells and rescues against glucocorticoid-induced osteoporosis by targeting BMP2.
Liu K; Jing Y; Zhang W; Fu X; Zhao H; Zhou X; Tao Y; Yang H; Zhang Y; Zen K; Zhang C; Li D; Shi Q
Bone; 2017 Apr; 97():130-138. PubMed ID: 28108317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
